End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
90.6 TWD | -3.72% | -10.30% | -20.53% |
Aug. 14 | Lin BioScience, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Apr. 25 | Lin BioScience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | - | Sales 2022 | - | Capitalization | 12.58B 402B |
---|---|---|---|---|---|
Net income 2021 | -435M -13.89B | Net income 2022 | -314M -10.03B | EV / Sales 2021 | - |
Net cash position 2021 | 805M 25.69B | Net cash position 2022 | 1.6B 51.05B | EV / Sales 2022 | - |
P/E ratio 2021 |
-29.4
x | P/E ratio 2022 |
-39.8
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 100% |
1 day | -3.72% | ||
1 week | -10.30% | ||
Current month | -16.88% | ||
1 month | -16.11% | ||
3 months | -21.22% | ||
6 months | -20.18% | ||
Current year | -20.53% |
Managers | Title | Age | Since |
---|---|---|---|
Yue Hsin Lin
FOU | Founder | 46 | 16-05-11 |
Wan Shan Chen
DFI | Director of Finance/CFO | 38 | 16-05-31 |
Hung Wei Chen
COO | Chief Operating Officer | 43 | 16-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hsien Hua Huang
BRD | Director/Board Member | - | 18-09-26 |
San Chien Tu
BRD | Director/Board Member | - | 18-09-26 |
Chan Yue Li
BRD | Director/Board Member | 52 | 16-10-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 115 M€ | +5.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 90.6 | -3.72% | 909,457 |
24-03-27 | 94.1 | -3.68% | 458,086 |
24-03-26 | 97.7 | -1.31% | 380,939 |
24-03-25 | 99 | -1.49% | 270,706 |
24-03-22 | 100.5 | -0.50% | 132,743 |
End-of-day quote Taipei Exchange, March 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-20.53% | 222M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |